Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.
CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig,...
Digitalisierung - was braucht das Land und was braucht die Wirtschaft am Beispiel einer Erfolgsgeschichte der Branche...
CENTOGENE today announced the expansion of its executive leadership team with the appointment of Sun Kim in Boston, MA...
Thank you to everyone who joined us during Rostock’s Night of Sciences at our HQ. It was a pleasure for us to welcome so...
Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for...
Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.
CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected...
As part of an exchange with senior business and academic leaders, and state of Mecklenburg-Vorpommern (M-V) government...
Agreement focused on identification of patients with Duchenne muscular dystrophy (DMD)
CENTOGENE, a rare disease company committed to improving the lives of rare disease patients by providing solutions that...
